# Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy

> **NCT01500642** · PHASE3 · COMPLETED · sponsor: **ASST Fatebenefratelli Sacco** · enrollment: 45 (actual)

## Conditions studied

- Pollen Allergy

## Interventions

- **BIOLOGICAL:** Slit One
- **BIOLOGICAL:** Slit One
- **BIOLOGICAL:** Slit One ragweed

## Key facts

- **NCT ID:** NCT01500642
- **Lead sponsor:** ASST Fatebenefratelli Sacco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500642, "Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01500642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*